Addressing the Challenges of Eosinophilia and Mastocytosis.
暂无分享,去创建一个
L. Rimsza | F. Craig | T. George | L. Quintanilla‐Martinez | Sa A. Wang | H. Horny | A. Orazi | K. Reichard | R. King | K. Kelemen
[1] G. Wertheim,et al. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders. , 2020, American journal of clinical pathology.
[2] L. Rimsza,et al. Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic Syndrome. , 2020, American journal of clinical pathology.
[3] L. Rimsza,et al. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. , 2020, American Journal of Clinical Pathology.